Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000200620 | SCV000250901 | uncertain significance | not provided | 2014-12-29 | criteria provided, single submitter | clinical testing | p.Ser496Asn (AGT>AAT): c.1487 G>A in exon 9 of the TGFBR1 gene (NM_004612.2) The S496N variant of unknown significance in the TGFBR1 gene has not been published as a mutation or been reported as a benign polymorphism to our knowledge. The S496N variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. Although S496N is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties, this substitution is conserved across species. Missense mutations in nearby residues (L486S, R487W, R487G, R487P, R487Q) have been reported in association with TGFBR1-related disorders, supporting the functional importance of this region of the protein. However, in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic mutation or a rare benign variant. This variant was found in TAADV2-1 |